CXCL10 and dengue disease: In light of the reported requirement of IP-10 for B cell activation (63), abnormal high IP-10 levels during late stages of disease in severe dengue patients (Figures 7G, H) suggest a possible mechanism for the contribution of B cell mediated immunopathology to severe dengue (20).